# Simed Medical breaks ground on vascular intervention device R&D and production base in Nanjing

Simed Medical, a subsidiary of Xinwei Medical, broke ground on a 1.34 billion yuan vascular intervention device R&D and production project in the Nanjing Biomedical Valley, Jiangsu Province. The facility will produce 800,000 femoral artery closure devices and 200,000 embolic coils annually.

- Type: New facility
- Announced: 2026-10-13
- Where: Nanjing, Jiangsu Province, China
- Value: $18.6M (134.0M CNY)
- Status: under construction
- Capacity: 800,000 femoral artery closure devices and 200,000 embolic coils per year
- Products: femoral artery closure devices, embolic coils, brain-computer interface equipment
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Simed Medical](https://endata.com/companies/94571.md)
- [Xinwei Medical](https://endata.com/companies/94572.md) (investor)

## Sources

- [js.news.cn](http://js.news.cn/20261013/171daa69653a42de993f06b06aeac901/c.html), 2026-10-13: "10月13日，思脉德医疗血管介入医疗器械研发及生产项目在江北新区南京生物医药谷开工。"

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.